Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization  by Arora, Subodh et al.
ease of the small pedal arteries in the past has been shown
to be incorrect.3 Distal arterial bypass grafting surgery to
the pedal arteries is common practice today in patients
with diabetes, and long-term follow-up studies have
shown encouraging results.4
Despite the lack of occlusive disease in the small pedal
arteries with diabetes, it is currently realized that there are
functional abnormalities in the microcirculation (ie, the
capillaries and arterioles), which seem to exist even in the
prediabetic stage at both the forearm and foot level.5,6 In
addition, diabetic neuropathy impairs the nerve axon
reflex that depends on healthy C-fiber nociceptor func-
tion and causes local vasodilation in response to a painful
stimulus. This condition further compromises the
vasodilatory response that is present in conditions of
stress, such as injury or inflammation, in the diabetic neu-
ropathic foot.7 This impairment may be one of the rea-
sons that some ulcers in the diabetic neuropathic foot fail
or are slow to heal despite successful lower extremity
revascularization.
Peripheral arterial disease is four to six times more
prevalent in patients with diabetes between the ages of 45
and 75 years than in those without diabetes, and the male
to female ratio approaches one.1,2 The pattern of occlusive
peripheral arterial disease with diabetes is such that
medium-sized arteries, mainly at the popliteal trifurcation,
are affected. However, there is sparing of the distal pedal
vessels from occlusive disease with diabetes, and the so-
called “small vessel disease” that referred to occlusive dis-
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Objective: The purpose of this study was the examination of the effect of successful large vessel revascularization on the
microcirculation of the neuroischemic diabetic foot.
Research design and methods: We measured the cutaneous microvascular reactivity in the foot in 13 patients with dia-
betes with peripheral arterial disease and neuropathy (group DI) before and 4 to 6 weeks after successful lower extrem-
ity arterial revascularization. We also compared them with age-matched and sex-matched groups of 15 patients with
diabetes and neuropathy, seven patients without neuropathy, and 12 healthy patients for control. We used single-point
and laser Doppler scan imaging for the measurement of the foot skin vasodilatation in response to heating to 44°C and
to iontophoresis of 1% acetylcholine (endothelial-dependent response) and 1% sodium nitroprusside (endothelial-inde-
pendent response).
Results: The group DI response to heat increased from 289% ± 90% before surgery (percent increase over baseline mea-
sured in volts) to 427% ± 61% (P < .05) after surgery but was still comparable with the response of the patients with
diabetes and neuropathy (318% ± 51%) and lower than the responses of the patients without neuropathy (766% ±
220%) and the healthy patients for control (891% ± 121%; P < .0001). The group DI acetylcholine response also
improved from 6% ± 4% before surgery to 26% ± 8% after surgery (P < .05) and was similar to the responses of patients
with diabetes and neuropathy (18% ± 3%) and patients without neuropathy (38% ± 8%) but still lower when compared
with the response of the patients for control (48% ± 9%; P < .001). The sodium nitroprusside response for group DI
improved from 10% ± 4% to 29% ± 9% (P < .05) and was similar to the responses of the neuropathic (25% ± 9%), non-
neuropathic (32% ± 6%), and control (40% ± 5%) groups. The group DI neurovascular response, which depends on the
healthy function of the C-fiber nociceptors, was similar at baseline (5% ± 9%) and after surgery (14% ± %10) and in the
neuropathic group (33% ± 21%), but it was dramatically reduced when compared with the nonneuropathic (110% ±
40%) and control (198% ± 54%) groups (P < .001).
Conclusion: Impaired vasodilation in the diabetic neuropathic lower extremity leads to functional ischemia, which
improves considerably but is not completely corrected with successful bypass grafting surgery. Therefore, patients with
diabetes and neuropathy may still be at high risk for the development of foot ulceration or the failure to have an exist-
ing ulcer heal despite adequate correction of large vessel blood flow.
(J Vasc Surg 2002;35:501-5.)
The effect of successful lower extremity arterial revas-
cularization (LEAR) on the impaired foot microcircula-
tion with diabetes is not known. In this study, we have
evaluated the effect of successful lower extremity arterial
reconstruction on the microcirculation of the ischemic
and neuropathic diabetic foot.
SUBJECTS AND METHODS
Subjects. Four groups of subjects who were matched for
age and gender were studied. The first group (group DI)
consisted of 13 patients with diabetic neuropathy and lower
extremity ischemia that needed lower extremity revascular-
ization for limb salvage. The second group consisted of 15
patients with diabetic neuropathy but no evidence of
ischemia (palpable pedal pulses and no history of claudica-
tion). The third group consisted of seven subjects with no
neuropathy or ischemia, and the fourth group consisted of
12 healthy patients for control. The first group was studied
before surgery and 4 to 6 weeks after successful lower
extremity revascularization. The main reason for the
allowance of 4 to 6 weeks after the operation was to minimize
the effects of postoperative edema that is present immediately
after the bypass grafting procedure. The remaining groups
were examined once. The demographics of the four groups
of subjects studied are shown in the Table.
All the subjects studied were nonsmokers or had not
smoked in the previous 6 months, had normotensive con-
ditions or conditions that were well controlled with no
more than two drugs, had serum creatinine levels of less
than 2 mg/dL with no microalbuminuria, and had no
severe dyslipidemia (triglyceride levels, >600 mg/dL; cho-
lesterol levels, >250 mg/dL). The protocol was approved
by the Ethics Committee/Institutional Review Board of
the medical center. Fully informed consent was obtained
from the volunteers who participated in the study.
Methods. The subjects were studied after an over-
night fast and abstinence from caffeine-containing bever-
ages for 24 hours. A general physical examination was
performed by a physician and included blood pressure
measurement. Neuropathy was diagnosed according to
previously described criteria.8 More specifically, the
Neuropathy Symptom Score, the Neuropathy Disability
Score, the Vibration Perception Threshold, and the
Semmes-Weinstein monofilaments were used as previ-
ously described.9 The systolic and diastolic blood pres-
sures were recorded to the nearest 2 mm Hg as the mean
of two measurements with the subjects seated. Height
and weight were also recorded, and the body mass index
was calculated.
Assessment of microvascular reactivity. All the vas-
cular reactivity tests were performed on the dorsum of the
foot immediately after the clinical examination with fast-
ing conditions according to methods that have been pre-
viously described.7 In summary, the subjects were seated
comfortably in a reclining chair in a quiet warm environ-
ment (room temperature, 21°C to 22°C). The cutaneous
microcirculation on the dorsum of the foot was evaluated
with laser Doppler scan perfusion imaging (LISCA
Development AB, Linkoping, Sweden) before and after
iontophoresis of 1% acetylcholine and 1% sodium nitro-
prusside (MICI iontophoresis system, Moor Instruments
LTD, Millwey, Devon, England). The term iontophoresis
denotes the introduction of soluble ions into the human
skin with the application of a small electric current (200 µA).
Acetylcholine was used for the evaluation of endothelium-
dependent vasodilatation (nitric oxide [NO]–mediated
response), and sodium nitroprusside was used to evaluate
endothelium-independent vasodilatation (direct smooth
muscle cell response). The cutaneous hyperemic response
to heat (44°C) also was evaluated at a site away from the
iontophoresis site with single-point laser Doppler scanning.
The data analysis was performed with the Minitab sta-
tistical package (Minitab, State College, Pa). The Kruskal-
Wallis test was used for nonparametric data, and analysis of
variance was used for parametric data for comparisons
among the various groups. The Fisher exact test was used
for the identification of differences between individual
groups. For the comparison of measurements before and
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Clinical characteristics of study groups
DI group DN group D group C group
No. of patients 13 15 7 12 
Male:female ratio 11:2 13:2 5:2 8:4
Age (years) 62 ± 3 60 ± 2 55 ± 6 58 ± 3
No. of patients with diabetes mellitus 1:12 5:8 5:2 –
type 1 or type 2*
Diabetes mellitus duration (y) 20 ± 3 22 ± 3 15 ± 4 –
Transcutaneous oxygen pressure† 40 ± 6 61 ± 4 70 ± 4 76 ± 2
Neuropathy Disability Score‡ 12 ± 4 18 ± 2 0.4 ± 0.3 0.7 ± 0.4
Vibration Perception Threshold‡ 43 ± 3 43 ± 4 18 ± 3 13 ± 2
Semmes-Weinstein filaments‡ 5.51 ± 0.34 6.59 ± 0.15 4.00 ± 0.23 4.07 ± 0.12
Data expressed as mean ± standard error of mean.
*DI group versus DN group and D group. 
†DI group versus DN, D, and C groups and DN group versus C group.
‡DI group and DN group versus D group and C group.
DI, Patients with diabetes with neuropathy and vascular disease; DN, patients with diabetes with neuropathy; D, patients with diabetes; C, patients
for control.
after revascularization in the first group, the paired t test
was used. The results were expressed as the mean ± stan-
dard error of the mean.
RESULTS
The patient demographics are depicted in the Table.
All the groups were matched for age, sex, comorbid con-
ditions, and, in the case of the patients with diabetes, the
duration of diabetes. All the patients in the DI group had
undergone successful distal bypass grafting surgery for
limb salvage. A total of 13 distal bypass grafting proce-
dures were performed. Of these, eight were from the
femoral to the dorsalis pedis artery and five were from the
femoral to the posterior tibial artery. There were eight
patients with tissue loss. Four patients had nonhealing
ulcers that healed 4 to 6 weeks after surgery. Two patients
had ulcers that were clean and healing. Two patients
underwent amputations of dry gangrenous toes soon after
the bypass grafting procedures, and their amputation sites
were healing satisfactorily 4 to 6 weeks after surgery. The
outcome of the operation was defined on clinical criteria,
such as healthy foot pulses (n = 7) and palpable graft
pulses (n = 13), nonobstructive continuous wave Doppler
scan signal over the graft, satisfactory wound healing for
ulcers, and amelioration of rest pain.
The cutaneous vasodilatory response to heating to
44°C (percent increase over baseline measured in volts)
was significantly improved after LEAR in the DI group
when compared with the preoperative measurement
(289% ± 90% versus 427% ± 61%; P < .05; Fig 1). However,
the postoperative response was significantly lower when
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compared with the responses in the patients who were dia-
betic without neuropathy and in the healthy patients for
control (766% ± 220% and 891% ± 121%, respectively; P
< .001), and the response was comparable with that in the
neuropathic group (318% ± 51%).
The acetylcholine response also improved from 6% ±
4% before surgery to 26% ± 8% after surgery (P < .05,
measured in volts) in the DI group (Fig 2). The postop-
erative response was similar to that of the patients with
neuropathic diabetes (18% ± 3%) and the patients with
Fig 1. Maximal hyperemic response to heat improved in patients
with neuropathy and peripheral arterial disease (DI group) after
successful bypass grafting operation (white bar) when compared
with baseline measurements before operation (black bar).
However, postoperative response was similar to that of patients
with neuropathy (DN group) and lower when compared with
patients with nonneuropathic diabetes (D group) and healthy
patients for control (C group). Results are on basis of single-point
laser probe measurements and are expressed as percent of increase
over baseline. *Before versus after surgery in DI group, P < .05.
†After surgery, DI group versus D and C groups, P < .0001.
Fig 2. A, Response to iontophoresis of acetylcholine (endothe-
lium dependent) improved in patients with neuropathy and
peripheral arterial disease (DI group) after successful bypass graft-
ing operation (white bar) when compared with baseline measure-
ments before operation (black bar). However, postoperative
response of DI group was similar to that of patients with neu-
ropathy (DN group) and patients with nonneuropathic diabetes
(D group) and was lower when compared with healthy patients
for control (C group). B, Response to iontophoresis of sodium
nitroprusside (endothelium independent) improved in patients
with neuropathy and peripheral arterial disease (DI group) after
successful bypass grafting operation (white bar) when compared
with baseline measurements before operation (black bar).
Postoperative response was similar to that of patients with neu-
ropathy (DN group), patients with nonneuropathic diabetes (D
group), and healthy patients for control (C group). Results are on
basis of laser Doppler scan imaging measurements and are
expressed as percent of increase over baseline. *Before versus after
surgery in DI group, P < .05. †After surgery, DI group versus C
group, P < .001.
A
B
nonneuropathic diabetes (38% ± 8%) but was still lower
when compared with the response of the healthy patients
for control (48% ± 9%; P < .001). The sodium nitroprus-
side response for the DI group improved from 10% ± 4%
to 29% ± 9% (P < .05, measured in volts) after surgery. The
postoperative response was similar to that of the patients
with neuropathic diabetes (25% ± 9%), the patients with
nonneuropathic diabetes (32% ± 6%), and the healthy
patients for control (40% ± 5%).
The group DI neurovascular response, which depends
on the healthy function of the C-fiber nociceptors, was
similar at baseline (5% ± 9%) and after surgery (14% ± 10%,
measured in volts; Fig 3). Both these responses were sim-
ilar to those of the patients with neuropathic diabetes
(33% ± 21) but were dramatically reduced when compared
with the responses of the patients with nonneuropathic
diabetes (110% ± 40%; P < .001) and the healthy patients
for control (198% ± 54%; P < .001).
DISCUSSION
In this study, we have shown that successful LEAR has
a favorable effect on the skin microcirculation. However,
this improvement does not reach the levels seen in healthy
subjects, and the postoperative vascular reactivity was sim-
ilar to the levels that were observed in patients with neu-
ropathic diabetes without any clinical peripheral arterial
disease. Finally, the nerve axon reflex–related response
that depends on the function of healthy C-fiber nocicep-
tors failed to show any improvement after LEAR.
Atherosclerotic arterial occlusive disease is common in
patients with diabetes and has a characteristic peritibial dis-
tribution with relative sparing of the foot vessels. The pat-
tern of atherosclerotic occlusive disease seen with diabetes
often presents several options with regard to arterial
reconstruction. Peripheral arterial disease is the most com-
mon indication for surgery in patients with diabetes.
Successful LEAR for the treatment of diabetic foot ulcer-
ation in the presence of ischemia and neuropathy plays a
major role in the healing of ulcers.2,4 However, some
ulcers do not heal or are slow to heal or do recur despite
the restoration of maximum perfusion to the foot via
bypass grafting surgery. This occurs even in the absence of
known factors that prevent or delay wound healing, such
as wound infection, poor wound care, and inadequate
weight offloading.
The cutaneous microcirculation of the diabetic and
neuropathic foot is known to be functionally impaired.5,7
Our study results have confirmed four abnormalities in the
physiology of the microcirculation in the diabetic foot in
the presence of ischemia and neuropathy. Thus, the stud-
ied patients with neuropathy and peripheral arterial disease
showed diminished cutaneous vasodilatory response to
heat, acetylcholine (endothelium-dependent vasodilata-
tion), sodium nitroprusside (smooth muscle cell response),
and the neurovascular response. The maximal hyperemic
response to heat and the endothelium-dependent vasodi-
latation improved after LEAR but were still less than
healthy levels. The same applies to the endothelium-
independent vasodilatation, but in this case, the response
approached the levels that were seen in patients with non-
neuropathic diabetes and did not differ statistically from
the response of the healthy patients for control. These
results indicate that the restoration of maximum blood
flow in the large vessels results in an increased blood flow
in the microcirculation. However, a successful bypass
grafting procedure cannot reverse the existing endothelial
dysfunction that is associated with diabetes, and therefore,
the postoperative endothelium-dependent vasodilatation
should not be expected to reach healthy levels. It is also of
interest that the improvement was more pronounced in
the endothelium-independent vasodilatation (response to
sodium nitroprusside), which indicated that the smooth
muscle cell was still able to vasodilate satisfactorily despite
the existence of neuropathy and endothelial dysfunction.
The foot skin microvascular reactivity is reduced when
compared with the forearm, not only in patients with dia-
betes but also in healthy subjects, and this may be a result
of the high capillary pressures related to the erect pos-
ture.10,11 In addition, neuropathy also has a detrimental
effect on the skin microcirculation.12-14 Reversal of
hypoxia has been shown to halt the progression of diabetic
neuropathy but not reverse the neuropathy that is already
present.15,16 Therefore, the results of this study with
regards to the nerve axon–related vasodilatation, which
did not change after LEAR, are not surprising. Recent
study results from our unit have shown that the nerve
axon reflex–related vasodilatation can account for as much
as one third of the total skin vasodilatation.17 Inability to
restore this vasodilatory response after LEAR may be
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Fig 3. Nerve axon reflex–related response remained unchanged
in patients with neuropathy and peripheral arterial disease (DI
group) after successful bypass grafting operation (white bar) when
compared with baseline measurements before operation (black
bar). Both preoperative and postoperative responses were similar
to those of patients with neuropathy (DN group) and lower when
compared with patients with nonneuropathic diabetes (D group)
and healthy patients for control (C group). Results are on the
basis of single-point laser probe measurements and are expressed
as percent of increase over baseline. *Before and after surgery, DI
group versus D and C groups, P < .001.
responsible for the failure of an existing ulcer to heal that
is observed in some patients with neuropathic diabetes.
Although the exact cause of neuropathy with diabetes
is not known, the microvascular endothelial and smooth
muscle cell vasodilatory response is known to be impaired
the most in patients with diabetes with ischemia and neu-
ropathy.7 Skin biopsy results from the dorsum of the foot
of patients with diabetes have also shown a significant
decrease in endothelial NO synthase expression (eNOS).7,18
Although the exact contribution of diabetes and neuropa-
thy to this reduced expression of eNOS is not known,
accumulating evidence suggests that this abnormality may
play a pivotal role in the impairment of wound healing
with diabetes.19,20 Therefore, it is not surprising that
methods that increase NO production or eNOS expres-
sion have shown promising results in wound healing in
experimental diabetes.21,22 We believe that the methods
we have used in this study can be helpful in the evaluation
of potential new treatments in human clinical trials for the
assessment of healing of diabetic foot ulcers.
Finally, a word of caution should be added regarding
the interpretation of these data. This study was mainly sta-
tistically powered for the examination of differences in the
vascular reactivity before and after LEAR and for the com-
parison of the levels that were achieved after surgery with
the healthy levels. Therefore, the study lacks the power to
compare possible differences between patients with nonis-
chemic and nonneuropathic diabetes and healthy patients
for control. We believe that this lack of power does not
affect the conclusions regarding the effect of LEAR on
microvascular reactivity. In addition, this study was not
designed to evaluate whether the inability to vasodilate is
related to reduced NO production, increased NO destruc-
tion, or inability of the smooth muscle cell to respond to
NO. Other investigators have attempted to study these
issues further.5-7,14,17 Because the subjects in the DI group
had baseline impairment in both endothelial-dependent
and endothelial-independent vasodilatation, by definition
the impaired sodium nitroprusside response may have
blunted the acetylcholine response. The interpretation of
the acetylcholine response in the presence of a defect in
the endothelial-independent vasodilatation is potentially
difficult. This is one of the weaknesses of the study.
However, after revascularization, both responses improved
significantly but did not reach levels seen in healthy con-
trol subjects, which is of clinical significance.
In summary, in this study, we have shown that
impaired vasodilation in the diabetic neuropathic lower
extremity leads to functional ischemia, which improves
but is not fully corrected with successful lower extremity
bypass grafting surgery. Therefore, patients with neuro-
pathic diabetes may still be at high risk for the develop-
ment of foot ulceration or for failure of an existing ulcer to
heal despite adequate correction of large vessel blood flow.
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